+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Vulvodynia Treatment Market by Type (Biofeedback & Physical Therapy, Intralesional Injections, Oral Treatment), Indication (Generalized Vulvodynia, Localized Vulvodynia), Providers - Forecast 2024-2030- Product Image
Global Vulvodynia Treatment Market by Type (Biofeedback & Physical Therapy, Intralesional Injections, Oral Treatment), Indication (Generalized Vulvodynia, Localized Vulvodynia), Providers - Forecast 2024-2030- Product Image
Sale

Global Vulvodynia Treatment Market by Type (Biofeedback & Physical Therapy, Intralesional Injections, Oral Treatment), Indication (Generalized Vulvodynia, Localized Vulvodynia), Providers - Forecast 2024-2030

  • PDF Icon

    Report

  • 193 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4807789
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vulvodynia Treatment Market size was estimated at USD 55.53 billion in 2023, USD 60.82 billion in 2024, and is expected to grow at a CAGR of 9.62% to reach USD 105.67 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vulvodynia Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vulvodynia Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vulvodynia Treatment Market, highlighting leading vendors and their innovative profiles. These include Amneal Pharmaceuticals, Inc., Cipla Ltd., Eli Lilly and Company, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Inc., GTO Pharmaceutical, LLC, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., Taro Pharmaceutical Industries Ltd., Upsher-Smith Laboratories, LLC, VuVatech LLC, and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Vulvodynia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Biofeedback & Physical Therapy
    • Intralesional Injections
    • Oral Treatment
    • Surgical Treatment
    • Topical Treatments
  • Indication
    • Generalized Vulvodynia
    • Localized Vulvodynia
  • Providers
    • Hospitals & Care Providers
    • Pharmaceutical & Biotechnology Companies
    • Research & Development Centres
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Vulvodynia Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vulvodynia Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Vulvodynia Treatment Market?
  4. What is the market share of the leading vendors in the Vulvodynia Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Vulvodynia Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Vulvodynia Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing knowledge of vulvodynia diagnostics among clinicians, particularly gynecologists
5.1.1.2. Developments in healthcare facilities and diagnostic services
5.1.1.3. Increase in the number of research and development activities
5.1.2. Restraints
5.1.2.1. Unidentified causes and limited diagnosis options
5.1.3. Opportunities
5.1.3.1. Doctors offering self-care and treatments for vulvodynia
5.1.3.2. Prolonged availability of off-label drugs
5.1.4. Challenges
5.1.4.1. Limited familiarity of health care providers with vulvodynia
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Vulvodynia Treatment Market, by Type
6.1. Introduction
6.2. Biofeedback & Physical Therapy
6.3. Intralesional Injections
6.4. Oral Treatment
6.5. Surgical Treatment
6.6. Topical Treatments
7. Vulvodynia Treatment Market, by Indication
7.1. Introduction
7.2. Generalized Vulvodynia
7.3. Localized Vulvodynia
8. Vulvodynia Treatment Market, by Providers
8.1. Introduction
8.2. Hospitals & Care Providers
8.3. Pharmaceutical & Biotechnology Companies
8.4. Research & Development Centres
9. Americas Vulvodynia Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Vulvodynia Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Vulvodynia Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Amneal Pharmaceuticals, Inc.
13.1.2. Cipla Ltd.
13.1.3. Eli Lilly and Company
13.1.4. GlaxoSmithKline PLC
13.1.5. Glenmark Pharmaceuticals Inc.
13.1.6. GTO Pharmaceutical, LLC
13.1.7. Hikma Pharmaceuticals PLC
13.1.8. Johnson & Johnson Services, Inc.
13.1.9. Novartis AG
13.1.10. Pfizer Inc.
13.1.11. Taro Pharmaceutical Industries Ltd.
13.1.12. Upsher-Smith Laboratories, LLC
13.1.13. VuVatech LLC
13.1.14. Zydus Lifesciences Limited
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. VULVODYNIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. VULVODYNIA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. VULVODYNIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VULVODYNIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VULVODYNIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VULVODYNIA TREATMENT MARKET DYNAMICS
FIGURE 7. VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2023 VS 2030 (%)
FIGURE 12. VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. VULVODYNIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. VULVODYNIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. VULVODYNIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VULVODYNIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VULVODYNIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. VULVODYNIA TREATMENT MARKET SIZE, BY BIOFEEDBACK & PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VULVODYNIA TREATMENT MARKET SIZE, BY INTRALESIONAL INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VULVODYNIA TREATMENT MARKET SIZE, BY ORAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VULVODYNIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. VULVODYNIA TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 12. VULVODYNIA TREATMENT MARKET SIZE, BY GENERALIZED VULVODYNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VULVODYNIA TREATMENT MARKET SIZE, BY LOCALIZED VULVODYNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 15. VULVODYNIA TREATMENT MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VULVODYNIA TREATMENT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. VULVODYNIA TREATMENT MARKET SIZE, BY RESEARCH & DEVELOPMENT CENTRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 28. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 31. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES VULVODYNIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 45. CHINA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 48. INDIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 54. JAPAN VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 72. THAILAND VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. DENMARK VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 85. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 88. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 91. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 94. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 100. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 109. NORWAY VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 112. POLAND VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 115. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 136. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM VULVODYNIA TREATMENT MARKET SIZE, BY PROVIDERS, 2018-2030 (USD MILLION)
TABLE 145. VULVODYNIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 146. VULVODYNIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. VULVODYNIA TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

  • Amneal Pharmaceuticals, Inc.
  • Cipla Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Inc.
  • GTO Pharmaceutical, LLC
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Taro Pharmaceutical Industries Ltd.
  • Upsher-Smith Laboratories, LLC
  • VuVatech LLC
  • Zydus Lifesciences Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 60.82 Billion
Forecasted Market Value ( USD ) by 2030 $ 105.67 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Vulvodynia Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Image

Vulvodynia Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • 181 Pages
  • Global
From
Vulvodynia Treatment Global Market Report 2024 - Product Image

Vulvodynia Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Vulvodynia Treatment Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Image

Vulvodynia Treatment Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • 89 Pages
  • Global
From
Female Sexual Pain Disorders. Evaluation and Management. Edition No. 2 - Product Image

Female Sexual Pain Disorders. Evaluation and Management. Edition No. 2

  • Book
  • 464 Pages
Diagnostic Gynecologic and Obstetric Pathology. Edition No. 3 - Product Image

Diagnostic Gynecologic and Obstetric Pathology. Edition No. 3

  • Book

About the Vulvodynia Drug Market

Vulvodynia is a chronic pain disorder that affects the vulva, the external female genitalia. It is estimated to affect up to 16% of women in the United States. The Vulvodynia Drug market is a subset of the Sexual and Reproductive Health Drugs market, which includes medications used to treat conditions related to sexual health, such as contraception, infertility, and sexually transmitted infections. Vulvodynia drugs are used to treat the pain associated with the condition, as well as to reduce inflammation and improve overall vulvar health. Common treatments include topical creams, oral medications, and physical therapy. In some cases, surgery may be recommended. The Vulvodynia Drug market is a growing field, with many companies developing new treatments and therapies. Some of the companies in the market include Allergan, Pfizer, Merck, and Bayer. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.